The initial public offering (IPO) of Dr. Agarwal's Healthcare, a provider of eye care services, is scheduled for next week. From January 29 to January 31, the Rs 3,027.2 crore mainboard issue will be available for subscription.
Agarwal's Healthcare's initial public offering (IPO) is entirely book-built. The IPO comprises an offer-for-sale (OFS) of 6.78 crore shares, totaling Rs 2,727.26 crore, and the fresh issuance of 75.3 lakh shares, totaling Rs 300 crore.
The BSE-listed Dr. Agarwal's Eye Hospital is owned by Dr. Agarwal's Healthcare. In its subsidiary, Dr. Agarwal's Eye Hospital, the parent company owned 71.9 per cent of the business.
Offer size and structure
The Rs 3,027.26 crore Dr. Agarwals Healthcare IPO is a book-built offering. The issue consists of an offer to sell 6.78 crore shares worth Rs 2,727.26 crores and a new issue of 0.75 crore shares worth Rs 300.00 crores.
Price band and minimum bid
The price range for Dr. Agarwals Healthcare's IPO is Rs 382 to Rs 402 per share. An application must have a minimum lot size of 35. Retail investors are required to invest a minimum of Rs 14,070.
For sNII and bNII, the minimum lot size investment is 15 lots comprising of 525 shares, totalling to Rs 2,11,050 and 72 lots comprising of 2,520 shares amounting to Rs 10,13,040, respectively.
Subscription and listing timeline
The subscription period for Dr. Agarwals Healthcare's initial public offering (IPO) begins on January 29, 2025, and ends on January 31, 2025. On Monday, February 3, 2025, the allocation for the Dr. Agarwals Healthcare IPO is anticipated to be finalised.
The tentative listing date for Dr. Agarwals Healthcare's initial public offering (IPO) is set for Wednesday, February 5, 2025, on the BSE and NSE.
GMP (Grey Market Price)
Given the grey market premium (GMP) of Rs 51, which indicates that each share would be listed for Rs 453, the shares of Dr. Agarwals Healthcare IPO are currently trading at their issue price of Rs 402 with a 12.69 per cent premium.
Registrar and book running lead manager
The Dr. Agarwals Healthcare IPO's book running lead managers are Kotak Mahindra Capital Company, Morgan Stanley India Company, Jefferies India Private, and Motilal Oswal Investment Advisors. The issue's registrar is Kfin Technologies.
Company financials
Despite a strong topline and operating performance, its net profit fell by 8 per cent to Rs 95 crore in FY24 as a result of higher taxes. Revenue rose from Rs 1,018 crore in FY23 to Rs 1,332 crore, a 31 per cent increase.
